基于血管性脂质的药物输送系统 (PhytoSolve) 用于在动物模型中治疗薄的子宫内膜

Ladan Haghighi1, Marziyeh Ajdary1, Azam Govahi1

  • 1Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.

Tissue & cell
|July 28, 2024
PubMed
概括

一种基于S75脂质的新型PhytoSolve药物递送系统,载有血管内皮生长因子 (VEGF),通过促进血管形成和增加子宫内膜厚度,有效地治疗薄子宫内膜.